| 1 |
Glioblastoma multiforme subterfuge as acute cerebral hemorrhage: A case report and literature review. ( 29844891
)
|
Richard S.A....You C.
|
2018 |
| 2 |
Evaluation of the relationship of erythrocyte membrane Na+/K+-ATPase enzyme activity and tumor response to chemoradiotherapy in patients diagnosed with locally advanced nonsmall cell lung cancer and glioblastoma multiforme. ( 29970705
)
|
Cetinkaya C.D....Koc M.
|
2018 |
| 3 |
Benzyl isothiocyanate inhibits human brain glioblastoma multiforme GBM 8401 cell xenograft tumor in nude mice in vivo. ( 29972272
)
|
Ma Y.S....Chung J.G.
|
2018 |
| 4 |
High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial. ( 29979390
)
|
Marinelli A....De Placido S.
|
2018 |
| 5 |
Venous thromboembolic complications with and without intermittent intraoperative and postoperative pneumatic compression in patients with glioblastoma multiforme using intraoperative magnetic resonance imaging. A retrospective study. ( 29859696
)
|
Ebeling M....Fahlbusch R.
|
2018 |
| 6 |
Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models. ( 29385725
)
|
Jandial R....Termini J.
|
2018 |
| 7 |
Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles. ( 29963263
)
|
GonzA!lez-Tablas M....Tabernero M.D.
|
2018 |
| 8 |
microRNAa89574 inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting zinc finger Ea89boxa89binding homeobox 1. ( 29901177
)
|
Mao Y....Wei C.
|
2018 |
| 9 |
Specifically Targeted Electromagnetic Fields Arrest Proliferation of Glioblastoma Multiforme U-87 Cells in Culture. ( 29848672
)
|
Narvaez C.J....Startari J.F.
|
2018 |
| 10 |
A case of subgaleal metastasis from glioblastoma multiforme. ( 29898273
)
|
Nguyen B....Pranavan G.
|
2018 |
| 11 |
Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients. ( 29444157
)
|
Lim W.H....Sohn C.H.
|
2018 |
| 12 |
Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiforme. ( 29953855
)
|
Zaman S....Blanck G.
|
2018 |
| 13 |
Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients. ( 29899827
)
|
Marx S....Rauch B.H.
|
2018 |
| 14 |
Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells. ( 29416731
)
|
Tarasova I.A....Gorshkov M.V.
|
2018 |
| 15 |
Hyaluronic Acid-Modified Micelles Encapsulating Gem-C<sub>12</sub>and HNK for Glioblastoma Multiforme Chemotherapy. ( 29397747
)
|
Liu X....Zhang Z.
|
2018 |
| 16 |
Early candidate biomarkers found from urine of glioblastoma multiforme rat before changes in MRI. ( 29372508
)
|
Ni Y....Gao Y.
|
2018 |
| 17 |
Enhanced radiosensitization of human glioblastoma multiforme cells with phosphorylated peptides derived from Gli2. ( 29880393
)
|
Han L....Jiang Y.
|
2018 |
| 18 |
Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients. ( 29442128
)
|
Peeken J.C....Combs S.E.
|
2018 |
| 19 |
Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment. ( 29387965
)
|
Stoyanov G.S....Tonchev A.B.
|
2018 |
| 20 |
A Rare Case of Concurrent Herpes Simplex Encephalitis and Glioblastoma Multiforme. ( 29492128
)
|
Sayal P....Highley R.
|
2018 |
| 21 |
Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience. ( 29889468
)
|
LukA!cs G....KovA!cs A.8.
|
2018 |
| 22 |
Glioblastoma multiforme: another potential application for<sup>68</sup>Ga-PSMA PET/CT as a guide for targeted therapy. ( 29387926
)
|
Kunikowska J....Leszek K.
|
2018 |
| 23 |
Reactive Astrocytes in Glioblastoma Multiforme. ( 29363044
)
|
Guan X....Sun D.
|
2018 |
| 24 |
Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme. ( 29849920
)
|
Fawzy M.S....Toraih E.A.
|
2018 |
| 25 |
ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: a clinicopathologic study. ( 29369420
)
|
Romano F.J....De Caro M.D.B.
|
2018 |
| 26 |
Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the <i>SGK1</i> Gene Are Associated with Poorer Survival. ( 29976632
)
|
Lehrer S....Rosenzweig K.E.
|
2018 |
| 27 |
Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy. ( 29378529
)
|
Chou S.Y....Huang E.Y.
|
2018 |
| 28 |
High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment. ( 29909500
)
|
Cheng W.Y....Chen J.P.
|
2018 |
| 29 |
Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme. ( 29910795
)
|
Jan C.I....Cho D.Y.
|
2018 |
| 30 |
CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB. ( 29415469
)
|
Barbagallo D....Purrello M.
|
2018 |
| 31 |
A Non-randomized Controlled Trial of EMDR on Affective Symptoms in Patients With Glioblastoma Multiforme. ( 29892240
)
|
Szpringer M....Amann B.L.
|
2018 |
| 32 |
Cucurbitacin B induces inhibitory effects via CIP2A/PP2A/Akt pathway in glioblastoma multiforme. ( 29393542
)
|
Qin S....Liu Y.
|
2018 |
| 33 |
Management of Elderly patients with Glioblastoma - Multiforme. ( 29376741
)
|
A A....m H.
|
2018 |
| 34 |
Cancer stem cells from peritumoral tissue of glioblastoma multiforme: the possible missing link between tumor development and progression. ( 29963265
)
|
Angelucci C....Sica G.
|
2018 |
| 35 |
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme. ( 29952031
)
|
Cetin B....Uner A.
|
2018 |
| 36 |
New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro. ( 29890725
)
|
Salaroglio I.C....Riganti C.
|
2018 |
| 37 |
Development of an exercise intervention as part of rehabilitation in a glioblastoma multiforme survivor during irradiation treatment: a case report. ( 29382243
)
|
Hansen A....Minet L.R.
|
2018 |
| 38 |
Stereotactic Radiosurgery in the Multimodality Management of Residual or Recurrent Glioblastoma Multiforme. ( 29393176
)
|
Niranjan A....Lunsford L.D.
|
2018 |
| 39 |
New aspects of glioblastoma multiforme revealed by similarities between neural and glioblastoma stem cells. ( 29383547
)
|
Kawamura Y....Nakashima K.
|
2018 |
| 40 |
Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming. ( 28785061
)
|
Bernstock J.D....Hallenbeck J.M.
|
2017 |
| 41 |
Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme. ( 29359162
)
|
Desai V....Bhushan A.
|
2017 |
| 42 |
Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme. ( 28952228
)
|
Jovanovic M....Maksimovic R.
|
2017 |
| 43 |
MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor. ( 28501897
)
|
Chen Y....Wang X.
|
2017 |
| 44 |
Biomarkers and therapeutic advances in glioblastoma multiforme. ( 28840962
)
|
Sasmita A.O....Ling A.P.K.
|
2017 |
| 45 |
Re-irradiation for recurrent glioblastoma multiforme. ( 28841798
)
|
Barney C....Palmer J.D.
|
2017 |
| 46 |
Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme. ( 28770902
)
|
Khan I....Shamim M.S.
|
2017 |
| 47 |
A 4-miRNAs signature predicts survival in glioblastoma multiforme patients. ( 28869437
)
|
Yuan G.Q....Pan Y.W.
|
2017 |
| 48 |
MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. ( 28187000
)
|
Chen W....Li F.C.
|
2017 |
| 49 |
MiR-429 suppresses glioblastoma multiforme by targeting SOX2. ( 28749077
)
|
Dong H....Guo M.
|
2017 |
| 50 |
A continuous-infusion dynamic MRI model at 3.0 Tesla for the serial quantitative evaluation of microvascular proliferation in an animal model of glioblastoma multiforme. ( 28078795
)
|
Underhill H.R.
|
2017 |
